You just read:

Gem Pharmaceuticals Presents Promising Phase 2 Data for GPX-150 in Sarcoma Patients at the 2016 ASCO Annual Meeting

News provided by

Gem Pharmaceuticals

Jun 07, 2016, 08:45 ET